SCHEMBL9050786

SCHEMBL9050786

CCCCCCCCCCCCc1c[nH]c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.54
KAT8 Q9H7Z6 2/20 0.49
PPARA Q07869 2/20 0.49
RARB P10826 7/20 0.47
ALDH1A1 P00352 2/20 0.47
RARA P10276 2/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
MTOR P42345 1/20 0.47
KMT2A Q03164 1/20 0.47
PPARG P37231 1/20 0.46
HCAR2 Q8TDS4 1/20 0.45
GPR84 Q9NQS5 1/20 0.45
RARG P13631 1/20 0.44
PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9148963 1.00 DAO (0.54) DAOKAT8PPARARARBALDH1A1
SCHEMBL8390700 1.00 DAO (0.54) DAOKAT8PPARARARBALDH1A1
SCHEMBL5858576 0.98 DAO (0.55) DAOKAT8PPARARARBALDH1A1
SCHEMBL6899153 0.86 DAO (0.60) DAOHCAR2
SCHEMBL9151583 0.83 BAZ2B (0.51) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL9154517 0.83 BAZ2B (0.51) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL9147935 0.83 BAZ2B (0.51) PPARAALDH1A1MEN1KMT2APPARG
SCHEMBL9196174 0.83 KDM4E (0.48) KAT8PPARAALDH1A1GPR84PTGS2
SCHEMBL9516348 0.81 MEN1 (0.44) DAOKAT8PPARAALDH1A1MEN1
SCHEMBL9151658 0.81 PPARA (0.44) PPARAPPARGGPR84PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8012573-A None JP disclosed
JP-H0812573-A FREE FATTY ACID REDUCING AGENT MITSUBISHI CHEM CORP 1996-01-16 JP disclosed
US-RE35096-E Antilipemic, anticholesterol, arteriosclerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1995-11-21 US disclosed
US-5082856-A Hyperlipemia, arteriosclerosis MITSUBISHI KASEI CORPORATION (JP) 1992-01-21 US disclosed
EP-0347902-A2 Pyrrolecarboxylic acid derivatives Mitsubishi Chemical Corporation (JP) 1989-12-27 EP disclosed